Thousands of newborn babies die or suffer serious illness each year for want of a cheap, readily available medical device to test for congenital heart disease, according to neonatal health experts.
Masimo
Nearly 30 device makers pledge to share data to make patients safer
The growing Patients Safety Movement has more than doubled its commitments from medtech companies over the course of a single year, with nearly 30 companies promising so far to make the data gathered by their devices available to anyone interested in improving patient care.
2013 year in review: Our 6 best interviews of the year
Masimo integrates with Acutronic’s neonatal monitors
Masimo officials discuss Q3 earnings results
Masimo beats The Street, raises outlook, shares slip anyway
Judge tosses whistleblowers’ lawsuit against Masimo
Masimo: Whistleblowers’ accusations not only false, but improper
Patient safety advocates take to Capitol Hill
Medical device executive turned patient safety advocate Joe Kiani told a U.S. Senate committee on healthcare Tuesday that the government can do more to stop preventable deaths in hospitals, including adding harsher payment penalties if a patient dies as a result of a preventable medical error or infection.
Whistleblowers accuse Masimo of concealing evidence
Masimo shares jump on Q2 earnings
Wall Street smiled on Masimo (NSDQ:MASI) yesterday with an 11% boost share prices in morning trading, which settled down to a 6.3% bump by the end of the day.
The California medical device maker gained strong favor after reporting strong sales and per-share earnings that beat analysts’ consensus estimates.